(16015810), N. J., (16015813), K. R. C., (14958336), H. H. M., (14942629), S. R., (16015816), C. T., (15038249), C. A. W., . . . (14942641), R. O. H. (2025). Table S3 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases.
Чикаго стиль цитування (17-те видання)(16015810), Noor Jailkhani, et al. Table S3 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases. 2025.
Стиль цитування MLA (9-ме видання)(16015810), Noor Jailkhani, et al. Table S3 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases. 2025.